Comparison Chart Tenax Therapeutics, Inc.

Stocks

TENX

US88032L6056

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-04 EDT			5-day change	1st Jan Change
13.82 ^USD	-3.56%		-12.53%	+13.37%

07-31	Tenax Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Canaccord Genuity Initiates Tenax Therapeutics at Buy With $35 Price Target	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	TENAX THERAPEUTICS, INC.	Other Biotechnology & Medical Research	-3.56%	-12.53%	+13.37%	+123.62%	-99.45%	821M